Search results for "Pharmaceutical Preparation"

showing 10 items of 213 documents

Pharmaceuticals and other urban contaminants threaten Amazonian freshwater ecosystems

2021

Abstract Urban areas in the Brazilian Amazon have grown at an unprecedented rate during the last years. About 90% of the wastewater produced by these urban areas are discharged untreated into Amazonian freshwater ecosystems, constituting a potential environmental pathway for pharmaceuticals and other chemicals consumed by modern societies (e.g. psychostimulants, personal-care products, hormones). The distribution of these chemicals into the Amazon River and their potential risks for freshwater biodiversity have not been evaluated so far. Here, we show the results of the largest chemical monitoring campaign conducted in the Amazon region. We assessed exposure patterns for 43 pharmaceuticals …

010504 meteorology & atmospheric sciencesAmazonianBiodiversity010501 environmental sciences01 natural sciencesFreshwater ecosystemFreshwater ecosystemRiversEnvironmental protectionUrbanizationTributaryparasitic diseasesChemical risk assessmentGE1-350CitiesEcosystem0105 earth and related environmental sciencesGeneral Environmental Sciencegeographygeography.geographical_feature_categoryAmazon rainforestAmazon RiverFreshwater ecosystemsfood and beveragesQ Science (General)BiodiversityContaminationEnvironmental sciencesWastewaterPharmaceutical PreparationsPharmaceuticalEnvironmental sciencePharmaceuticalsWater Pollutants Chemicalgeographic locationsEnvironmental MonitoringEnvironment International
researchProduct

Consumo de medicamentos en el embarazo y riesgo de anomalías congénitas en la Comunitat Valenciana

2017

Resumen: Antecedentes: El consumo de medicamentos durante el embarazo se ha incrementado en las últimas décadas. Objetivo: Identificar el riesgo de anomalías congénitas (AC) asociado a la utilización de medicamentos en atención ambulatoria en embarazadas residentes en la Comunitat Valenciana. Métodos: Estudio de casos-controles, considerando caso a menores de un año nacidos vivos en 2009-2010 diagnosticados de AC y residentes en la Comunitat Valenciana, obtenidos del registro poblacional de AC. Los controles se seleccionaron del Registro de Metabolopatías y la medicación prescrita y dispensada se obtuvo del módulo Gestión Integral de Prestación Farmacéutica. Se calcularon las odds ratio (OR…

03 medical and health sciences030219 obstetrics & reproductive medicine0302 clinical medicineRisk factorsPregnancyValencia RegionPediatrics Perinatology and Child HealthPharmaceutical preparations030212 general & internal medicinePediatricsRJ1-570Congenital abnormalitiesAnales de Pediatría
researchProduct

Drug metabolism by cultured human hepatocytes: how far are we from the in vivo reality?

2004

The investigation of metabolism is an important milestone in the course of drug development. Drug metabolism is a determinant of drug pharmacokinetics variability in human beings. Fundamental to this are phenotypic differences, as well as genotypic differences, in the expression of the enzymes involved in drug metabolism. Genotypic variability is easy to identify by means of polymerase chain reaction-based or DNA chip-based methods, whereas phenotypic variability requires direct measurement of enzyme activities in liver, or, indirectly, measurement of the rate of metabolism of a given compound in vivo. There is a great deal of phenotypic variability in human beings, only a minor part being…

0301 basic medicineDrugDiclofenacmedia_common.quotation_subjectBiologyPharmacologyToxicologyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineCytochrome P-450 Enzyme SystemIn vivoGenetic variationmedicineHumansCells Culturedmedia_common030102 biochemistry & molecular biologyAnti-Inflammatory Agents Non-SteroidalGenetic VariationGeneral MedicineMetabolismIn vitroMedical Laboratory TechnologyDrug developmentBiochemistryLiverPharmaceutical Preparations030220 oncology & carcinogenesisMultigene FamilyHepatocytesAceclofenacDrug metabolismmedicine.drugAlternatives to laboratory animals : ATLA
researchProduct

Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing.

2016

Drug attrition rates due to hepatotoxicity are an important safety issue considered in drug development. The HepG2 hepatoma cell line is currently being used for drug-induced hepatotoxicity evaluations, but its expression of drug-metabolizing enzymes is poor compared with hepatocytes. Different approaches have been proposed to upgrade HepG2 cells for more reliable drug-induced liver injury predictions. Areas covered: We describe the advantages and limitations of HepG2 cells transduced with adenoviral vectors that encode drug-metabolizing enzymes for safety risk assessments of bioactivable compounds. Adenoviral transduction facilitates efficient and controlled delivery of multiple drug-metab…

0301 basic medicineDrugmedia_common.quotation_subjectGenetic VectorsBiologyPharmacologyToxicologyENCODERisk AssessmentAdenoviridae03 medical and health sciencesToxicity TestsmedicineAnimalsHumansmedia_commonPharmacologyLiver injurychemistry.chemical_classificationReproducibility of ResultsGeneral MedicineHep G2 Cellsmedicine.disease030104 developmental biologyEnzymemedicine.anatomical_structureDrug developmentchemistryPharmaceutical PreparationsHepg2 cellsHepatocyteDrug DesignCancer researchHepatocytesChemical and Drug Induced Liver InjuryDrug metabolismExpert opinion on drug metabolismtoxicology
researchProduct

A critical evaluation of Amicon Ultra centrifugal filters for separating proteins, drugs and nanoparticles in biosamples

2015

Amicon(®) Ultra centrifugal filters were critically evaluated for various sample preparations, namely (a) proteome fractionation, (b) sample cleanup prior to liquid chromatography mass spectrometry (LC-MS) measurement of small molecules in cell lysate, and (c) separating drug-loaded nanoparticles and released drugs for accurate release profiling in biological samples. (a) Filters of supposedly differing molar mass (MM) selectivity (10, 30, 50 and 100K) were combined to attempt fractionation of samples of various complexity and concentration. However, the products had surprisingly similar MM retentate/filtrate profiles, and the filters were unsuited for proteome fractionation. (b) Centrifuga…

0301 basic medicineLysisProteomeClinical BiochemistryPharmaceutical ScienceCentrifugationFractionationChemical Fractionation01 natural sciencesAnalytical Chemistry03 medical and health sciencesTandem Mass SpectrometryLiquid chromatography–mass spectrometryDrug DiscoveryCentrifugationSpectroscopyMolar massAqueous solutionChromatographyChemistry010401 analytical chemistryProteinsSmall molecule0104 chemical sciencesMolecular Weight030104 developmental biologyPharmaceutical PreparationsProteomeSolventsNanoparticlesChromatography LiquidJournal of Pharmaceutical and Biomedical Analysis
researchProduct

Molecular epidemiology and drug-resistance mechanisms in carbapenem-resistant Klebsiella pneumoniae isolated in patients from a tertiary hospital in …

2020

Abstract Objectives The aim of this study has been to characterize carbapenem-resistant Klebsiella pneumoniae isolates and to determine the resistance mechanisms involved, the clonal relationship between strains and clinical and demographical data of the infected patients. Methods Clinical and demographical data from patients were collected and statistically analysed. Antimicrobial susceptibility testing was performed and resistance genes were detected both phenotypically and genotypically. Conjugation assays were performed to show horizontal transferability of resistance genes. Clonal relationship was also studied. Next-generation sequencing (NGS) was performed to obtain information regard…

0301 basic medicineMicrobiology (medical)Klebsiella pneumoniaeTetracycline030106 microbiologyImmunologyVirulenceDrug resistanceResistance mechanismsMicrobiologyMicrobiologyTertiary Care Centers03 medical and health sciences0302 clinical medicinePlasmidGenotypemedicineImmunology and AllergyHumans030212 general & internal medicineMolecular EpidemiologyMolecular epidemiologybiologybiology.organism_classificationCarbapenemasesQR1-502Klebsiella InfectionsKlebsiella pneumoniaeCarbapenemsPharmaceutical PreparationsSpainMultilocus sequence typingmedicine.drugJournal of Global Antimicrobial Resistance
researchProduct

A Simple Method to Predict Blood-Brain Barrier Permeability of Drug- Like Compounds Using Classification Trees

2017

Background: To know the ability of a compound to penetrate the blood-brain barrier (BBB) is a challenging task; despite the numerous efforts realized to predict/measure BBB passage, they still have several drawbacks. Methods: The prediction of the permeability through the BBB is carried out using classification trees. A large data set of 497 compounds (recently published) is selected to develop the tree model. Results: The best model shows an accuracy higher than 87.6% for training set; the model was also validated using 10-fold cross-validation procedure and through a test set achieving accuracy values of 86.1% and 87.9%, correspondingly. We give a brief explanation, in structural terms, o…

0301 basic medicineQuantitative structure–activity relationshipComputer scienceDatasets as TopicQuantitative Structure-Activity Relationshipcomputer.software_genre01 natural sciencesPermeability03 medical and health sciencesMolecular descriptorDrug DiscoveryInternational literatureComputer SimulationTraining setDecision tree learningDecision Trees0104 chemical sciences010404 medicinal & biomolecular chemistry030104 developmental biologyPharmaceutical PreparationsBlood-Brain BarrierTest setData miningBlood brain barrier permeabilitycomputerAlgorithmsDecision tree modelMedicinal Chemistry
researchProduct

Strategies against nonsense: oxadiazoles as translational readthrough-inducing drugs (TRIDs)

2019

This review focuses on the use of oxadiazoles as translational readthrough-inducing drugs (TRIDs) to rescue the functional full-length protein expression in mendelian genetic diseases caused by nonsense mutations. These mutations in specific genes generate premature termination codons (PTCs) responsible for the translation of truncated proteins. After a brief introduction on nonsense mutations and their pathological effects, the features of various classes of TRIDs will be described discussing differences or similarities in their mechanisms of action. Strategies to correct the PTCs will be presented, particularly focusing on a new class of Ataluren-like oxadiazole derivatives in comparison …

0301 basic medicinemedia_common.quotation_subjectNonsenseNonsense mutationRegulatorSettore BIO/11 - Biologia MolecolareReviewComputational biologyBiologyOxadiazoleCatalysiscystic fibrosislcsh:ChemistryInorganic Chemistry03 medical and health sciences0302 clinical medicineAtalurenTranslational readthrough inducing drugsPhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologyGeneSpectroscopymedia_commonNonsense mutationOrganic ChemistryTranslational readthroughoxadiazolesPremature termination codonTranslation (biology)General MedicineSettore CHIM/06 - Chimica OrganicaSmall moleculeSettore CHIM/08 - Chimica FarmaceuticaTransmembrane proteinComputer Science ApplicationsSettore BIO/18 - Genetica030104 developmental biologyPharmaceutical Preparationslcsh:Biology (General)lcsh:QD1-999Codon NonsenseProtein Biosynthesis030220 oncology & carcinogenesisCystic fibrosi
researchProduct

Are there positive lessons for Italy's NHS resulting from the Covid-19 pandemic?

2020

The authors evaluate the importance of prevention measures and health care from their own experience and briefly analyse the factors that may have contributed to the rapid spread of Covid-19 in Italy, and hope this will feed into appropriate and new and improved health policies.

2019-20 coronavirus outbreakNational Health ProgramsCoronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINEStrategic StockpileBetacoronavirusSettore MED/43 - Medicina LegalePolitical scienceEnvironmental healthPandemicHealth careHumansPandemicsPersonal Protective EquipmentStrategic StockpileHealth policyHealth Services Needs and DemandbiologySARS-CoV-2business.industryHealth PolicyCOVID-19General Medicinebiology.organism_classificationItalyPharmaceutical PreparationsCommunicable Disease Controlcoronavirus pandemic Covid-19 health care health policies lessons Coronavirus Infections Health Services Needs and Demand Humans Italy Pandemics Personal Protective Equipment Pharmaceutical Preparations Pneumonia Viral Strategic Stockpile Betacoronavirus Communicable Disease Control Health Policy National Health ProgramsCoronavirus InfectionsbusinessBetacoronavirus
researchProduct

Buccal drug delivery: what's new and what does the future hold?

2014

The buccal mucosa is the stratified squamous epithelial tissue inside lining of the cheeks. It is a favorable site of drug absorption since the tissue is non-keratinized, relatively immobile and strongly supplied with blood by a dense capillary-vessel network; moreover, it is highly tolerant to allergens, resistant to potentially harmful agents and has a relatively low enzymatic activity. The tissue consents quick onset of effect, offers an easily accessible and generally well-accepted site for drug delivery, is a useful route of administration in patients in an unconscious state (e.g., when swallowing is impaired), and is suitable for retentive dosage forms of administration. Buccal mucosa…

3003Drugmedia_common.quotation_subjectChemistry PharmaceuticalPharmaceutical ScienceDentistryPharmacologyDosage formRoute of administrationDrug Delivery SystemsPharmacokineticsMucositisMedicineAnimalsHumansBuccal dosage formmedia_commonDosage FormsDrug Carriersbusiness.industryLocoregional/systemic treatmentMedicine (all)Mouth MucosaAdministration BuccalTransmucosal deliveryBuccal administrationmedicine.diseaseBioavailabilityPharmaceutical PreparationsSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryBuccal mucosaDiffusion of InnovationbusinessForecastingTherapeutic delivery
researchProduct